Literature DB >> 1309449

Prevalence of anti-hepatitis C virus antibodies among patients with alcoholic liver disease, supplemented by 4-RIBA.

P Laurent-Puig, E Dussaix, Y Lecoz, P Martes, C Buffet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1309449     DOI： 10.1007/bf01308363

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  5 in total

1.  Differentiation between specific and non-specific hepatitis C antibodies in chronic liver disease.

Authors:  J J Gray; T G Wreghitt; P J Friend; D G Wight; V Sundaresan; R Y Calne
Journal:  Lancet       Date:  1990-03-10       Impact factor: 79.321

2.  Hepatitis C virus antibody.

Authors:  P P Mortimer; B J Cohen; P A Litton; E M Vandervelde; M F Bassendine; A M Brind; M H Hambling
Journal:  Lancet       Date:  1989-09-30       Impact factor: 79.321

3.  Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.

Authors:  J Bruix; J M Barrera; X Calvet; G Ercilla; J Costa; J M Sanchez-Tapias; M Ventura; M Vall; M Bruguera; C Bru
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

4.  Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury.

Authors:  A Parés; J M Barrera; J Caballería; G Ercilla; M Bruguera; L Caballería; R Castillo; J Rodés
Journal:  Hepatology       Date:  1990-12       Impact factor: 17.425

5.  Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?

Authors:  I G McFarlane; H M Smith; P J Johnson; G P Bray; D Vergani; R Williams
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321
  5 in total
  1 in total

1.  Clinical sequelae of hepatitis C acquired from injection drug use.

Authors:  M J Tong; N S el-Farra
Journal:  West J Med       Date:  1996-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.